BPC-157 — "Body Protective Compound 157" — is a 15-amino-acid sequence isolated from a larger protein naturally present in human gastric juice. Of all the peptides on the market, BPC-157 has the deepest body of preclinical research behind it, with studies dating back to the early 1990s exploring its effects on tissue repair, blood vessel formation, and gut healing.
The clinical interest is rooted in a remarkably consistent observation: BPC-157 appears to accelerate repair in a wide range of tissue types — tendons, ligaments, muscle, gut lining, even some types of nerve tissue. The mechanism isn't fully understood, but evidence points to upregulation of growth factors, improved blood vessel formation in injured areas, and support of the body's natural inflammatory resolution.
In a clinical setting, Dr. Dubroff prescribes BPC-157 most commonly for patients dealing with chronic tendinopathies, soft-tissue injuries that have not responded to physical therapy, post-surgical recovery, and chronic gut conditions where intestinal lining repair is the underlying goal.
BPC-157 isn't a cure-all and Dr. Dubroff doesn't position it as one. These are the use cases where the clinical case is strongest and where patients tend to see the clearest results.
Chronic tendinopathy (tennis elbow, golfer's elbow, patellar tendinitis, Achilles), ligament strains that haven't healed with rest and PT, and partial tears. BPC-157 supports the body's repair response in tissues that historically heal slowly due to limited blood supply.
Used to support tissue repair following orthopedic surgery, soft-tissue procedures, or other interventions where the speed and quality of healing matter. Often run for 4-8 weeks post-procedure.
Because BPC-157 was originally isolated from gastric juice, its strongest evidence is in GI tissue repair. Used as part of protocols for leaky gut, ulcerative inflammation, NSAID-induced GI damage, and chronic gut lining concerns.
For athletes and active patients dealing with muscle injuries — particularly partial tears or chronic strain patterns that keep flaring up. BPC-157 supports the natural repair sequence and can shorten time-to-recovery.
Often paired with stem cell or PRP injections to support tissue repair in osteoarthritic joints. BPC-157 is sometimes used in the weeks following a regenerative injection to amplify the healing response.
Patients dealing with chronic low-grade inflammation underlying multiple symptoms — particularly when localized to specific tissue. Used as part of broader protocols addressing inflammation drivers.
Book a free consultation. Dr. Dubroff will tell you honestly whether BPC-157 is likely to help in your specific case — and what a clinical protocol would look like.